Severe acute bronchiolitis in children: etiology, therapy, effectiveness of 3% hypertonic saline containing sodium hyaluronate

Introduction. Acute bronchiolitis (АB) is a common  infection  in children  under  the  age of 2 years. In modern  clinical protocols, routine use of the studied drugs is not recommended. The effectiveness of a 3% hypertonic sodium chloride solution (HSCS) at vol.

Аim. Тo study the etiology, risk factors, the therapy of acute care in children in intensive  care units (ICU), the effectiveness of inhalations with 3% HSCS with hyaluronate sodium (HS) in comparison  with therapy without  the inclusion of this drug.

Materials and methods. The medical documentation of 54 patients with AB from January 2021 to January 2023 who were treated in the ICU was analyzed. An ambispective comparative study of the effectiveness of therapy  of 3% HSCS with HS AB was conducted  in comparison  with historical control.

Results. Respiratory syncytial viral (RSV) etiology was established in 50% of patients. The most common risk factor for the disease was the  age younger than  3 months  (40.7%). The presence of risk factors for severe  course  of acute  respiratory  failure had an impact  on the average  bed-day and on the need  for respiratory  support  (p = 0.04), in addition  to which patients often  received drug therapy. There were no statistically significant differences  in the terms of hospitalization, the duration  of respiratory support depending on the appointment of 3% of HSCS with HS (p > 0.05), however, there  was an improvement in clinical and functional dynamics estimated by the modified clinical scale of Wood’s asthma  by the 2nd day of the disease.

Conclusion. AB in ICU patients most  often  has RSV etiology, developing in the  presence of risk factors  for severe  course. The influence  of modern  guidelines for the treatment of AB in the ICU remains  controversial. The addition  of 3% HSCS with HS can improve the flow of AB.

1. Baranov A.A., Namazova-Baranova L.S., Artemova I.V., Bakradze M.D., Vishneva E.A., Davydova E.V. et al. Acute bronchiolitis: сlinical recommendations. Moscow; 2021. 22 p. (In Russ.) Available at: https://diseases.medelement.com/disease/%D0%BE%D1%81%D1%82%D1%80%D1%8B%D0%B9-%D0%B1%D1%80%D0%BE%D0%BD%D1%85%D0%B8%D0%BE%D0%BB%D0%B8%D1%82-%D1%83-%D0%B4%D0%B5%D1%82%D0%B5%D0%B9-%D0%BA%D1%80-%D1%80%D1%84-2021/17056.

2. Schlapbach L.J., Straney L., Gelbart B., Alexander J., Franklin D., Beca J. et al. Burden of disease and change in practice in critically ill infants with bronchiolitis. Eur Respir J. 2017;49(6):1601648. https://doi.org/10.1183/13993003.01648-2016.

3. Ovsyannikov D.Y. (ed.). Neonatal pulmonology. Moscow; 2022. 168 р. (In Russ.) Available at: https://raspm.ru/files/pulmonologiya.pdf.

4. Tsygankov A.E., Ovsyannikov D.Yu., Afukov I.I., Solodovnikova O.N., Gosteva O.M., Kostin D.M. et al. A modern view on the treatment of acute bronchiolitis in pediatric intensive care units: a review. Annals of Critical Care. 2022;(3):111–123. (In Russ.) https://doi.org/10.21320/1818-474X-2022-3-111-123.

5. National Collaborating Centre for Women’s and Children’s Health (UK). Bronchiolitis: Diagnosis and Management of Bronchiolitis in Children. London: National Institute for Health and Care Excellence (NICE); 2015. Available at: https://pubmed.ncbi.nlm.nih.gov/26065055.

6. Ovsyannikov D.Yu., Tsverava A.G., Krsheminskaya I.V., Tsygankov A.E., Mikheeva A.A., Berezhanskiy P.V. et al. Patients with bronchopulmonary dysplasia are at risk of severe bronchiolitis caused by respiratory syncytial virus. Neonatology: News, Opinions, Training. 2022;(4):63–74. (In Russ.) https://doi.org/10.33029/2308-2402-2022-10-4-63-74.

7. White B.R., Cadotte N., McClellan E.B., Presson A.P., Bennett E., Smith A.G., Aljabari S. High-Frequency Percussive Ventilation in Viral Bronchiolitis. Respir Care. 2022;67(7):781–788. https://doi.org/10.4187/respcare.09350.

8. Pelletier J.H., Au A.K., Fuhrman D., Clark R.S.B., Horvat C. Trends in Bronchiolitis ICU Admissions and Ventilation Practices: 2010–2019. Pediatrics. 2021;147(6):e2020039115. https://doi.org/10.1542/peds.2020-039115.

9. Mecklin M., Heikkilä P., Korppi M. The change in management of bronchiolitis in the intensive care unit between 2000 and 2015. Eur J Pediatr. 2018;177(7):1131–1137. https://doi.org/10.1007/s00431-018-3156-4.

10. Mandelberg A., Amirav I. Hypertonic saline or high volume normal saline for viral bronchiolitis: Mechanisms and rationale. Pediatr Pulmonol. 2010;45(1):36–40. https://doi.org/10.1002/ppul.21185.

11. Ziment I. Respiratory Pharmacology and Therapeutics. Philadelphia, PA: Saunders; 1978. Available at: https://lib.ugent.be/catalog/rug01:000907759.

12. Assouline G., Leibson V., Danon A. Stimulation of prostaglandin output from rat stomach by hypertonic solutions. Eur J Pharmacol. 1977;44(3):271–273. https://doi.org/10.1016/0014-2999(77)90073-5.

13. Heikkila P., Korppi M. Hypertonic saline in bronchiolitis: an updatedmetaanalysis. Arch Dis Child. 2021;106(1):102. https://doi.org/10.1136/archdis-child-2020-319048.

14. Brooks C.G., Harrison W.N., Ralston S.L. Association Between Hypertonic Saline and Hospital Length of Stay in Acute Viral Bronchiolitis: A Reanalysis of 2 Meta-analyses. JAMA Pediatr. 2016;170(6):577–584. https://doi.org/10.1001/jamapediatrics.2016.0079.

15. Stobbelaar K., Kool M., de Kruijf D., Van Hoorenbeeck K., Jorens P., De Dooy J., Verhulst S. Nebulised hypertonic saline in children with bronchiolitis admitted to the paediatric intensive care unit: A retrospective study. J Paediatr Child Health. 2019;55(9):1125–1132. https://doi.org/10.1111/jpc.14371.

16. Matics T.J., Sanchez-Pinto LN. Adaptation and Validation of a Pediatric Sequential Organ Failure Assessment Score and Evaluation of the Sepsis-3 Definitions in Critically Ill Children. JAMA Pediatr. 2017;171(10):e172352. https://doi.org/10.1001/jamapediatrics.2017.2352.

17. Solodovnikova O.N., Dyagileva A.U., Erovichenkov A.A., Troshyansky D.V., Gosteva O.M., Nurpeysova A.К. et al. Standardization of approaches to early detection of risks for clinical deterioration in children treated in hospitals for infectious diseases. Clinical Practice in Pediatrics. 2023;18(1):8–15. (In Russ.). https://doi.org/10.20953/1817-7646-2023-1-8-15.

18. Parshuram C.S., Duncan H.P., Joffe A.R., Farrell C.A., Lacroix J.R., Middaugh K.L. et al. Multicentre validation of the bedside paediatric early warning system score: a severity of illness score to detect evolving critical illness in hospitalised children. Crit Care. 2011;15(4):R184. https://doi.org/10.1186/cc10337.

19. Duarte-Dorado D.M., Madero-Orostegui D.S., Rodriguez-Martinez C.E., Nino G. Validation of a scale to assess the severity of bronchiolitis in a population of hospitalized infants. J Asthma. 2013;50(10):1056–1061. https://doi.org/10.3109/02770903.2013.834504.

20. Pierce H.C., Mansbach J.M., Fisher E.S., Macias C.G., Pate B.M., Piedra P.A. et al. Variability of intensive care management for children with bronchiolitis. Hosp Pediatr. 2015;5(4):175–184. https://doi.org/10.1542/hpeds.2014-0125.

21. Marcos-Morales A., García-Salido A., Leoz-Gordillo I., de Lama Caro-Patón G., Martínez de Azagra-Garde A., García-Teresa M.Á. et al. Respiratory and pharmacological management in severe acute bronchiolitis: Were clinical guidelines not written for critical care? Arch Pediatr. 2021;28(2):150–155. https://doi.org/10.1016/j.arcped.2020.11.007.

22. Zhang L., Mendoza-Sassi R.A., Wainwright C., Klassen T.P. Nebulised hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database Syst. Rev. 2017;12(12):CD006458. https://doi.org/10.1002/14651858.CD006458.pub4.

23. Wang Z.Y., Li X.D., Sun A.L., Fu X.Q. Efficacy of 3% hypertonic saline in bronchiolitis: A meta-analysis. Exp Ther Med. 2019;18(2):1338–1344. https://doi.org/10.3892/etm.2019.7684.

24. Lin J., Zhang Y., Song A., Ying L., Dai J. Exploring the appropriate dose of nebulized hypertonic saline for bronchiolitis: a dose-response meta-analysis. J Investig Med. 2022;70(1):46–54. https://doi.org/10.1136/jim-2021-001947.

25. Hancock D.G., Charles-Britton B., Dixon D.L., Forsyth K.D. The heterogeneity of viral bronchiolitis: A lack of universal consensus definitions. Pediatr Pulmonol. 2017;52(9):1234–1240. https://doi.org/10.1002/ppul.23750.